Despite being easy and inexpensive to treat, a group of common bacterial and parasitic infections kill hundreds of thousands of people in tropical countries each year. In a new paper, Yale SOM’s Teresa Chahine and her co-authors map the complex system of stakeholders surrounding the diseases and identify key leverage points for making progress.
In 1957, a novel strain of the flu spread around the world, the first global outbreak since the 1918 flu pandemic. More than one million people died, 116,000 of them in the United States. But schooling, shopping, and sporting events went on as normal, and the pandemic has largely faded from public memory.
A new federal law prevents patients from being billed by out-of-network doctors after being treated in an in-network hospital. We asked Prof. Fiona Scott Morton, whose research helped bring the practice to light, what the new law will mean for patients and healthcare costs.
New research from Yale SOM’s Heather Tookes and Matthew Spiegel finds that mask mandates, closing restaurants, and stay-at-home orders are all effective at saving lives, but other commonly used measures can actually worsen the spread of the pandemic.
Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.
Earlier this year, a team of Yale researchers showed that the concentration of COVID-19 RNA in sewage mirrors the spread of the disease through a population. In a new study, they find that testing sewage can serve as an early indicator of an outbreak relative to hospitalizations.
Efforts in the late 1960s to desegregate hospitals in the American South did not significantly contribute to improvements in the Black infant mortality rate, finds a new study co-authored by Dean Kerwin Charles.
Epidemiological models have played an influential role in governments’ responses to the COVID-19 pandemic. Yale SOM’s Edieal Pinker takes a look back at one of the most influential models and argues that such rigorous efforts at understanding the likely course of the disease, while imperfect, are critical to good decision making.